Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100047529Phase 4Recruiting
Phase 4, open-label trial of phenylephrine and norepinephrine in hypotension (2 arms), sponsored by Zhejiang University. Primary endpoint: Umbilical artery pH. Started May 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100047529.